MIRASOL PATHOGEN REDUCTION TECHNOLOGY MODULATES PLATELET OXIDATIVE STRESS

被引：0
|
作者：
Johnson, L. N. [1 ]
Marks, D. C. [1 ]
机构：
[1] Australian Red Cross Blood Serv, Alexandria, Australia
来源：
VOX SANGUINIS | 2013年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 133
页数：2
相关论文
共 50 条
  • [41] Effect of Mirasol pathogen reduction technology system on in vitro quality of MCS plus apheresis platelets
    Mastroianni, Maria Adele
    Llohn, Abid Hussain
    Akkok, Cigdem Akalin
    Skogheim, Ruby
    Odegaard, Elna Rathe
    Nybruket, Monica Jenssen
    Flesland, Annika
    Mousavi, Seyed Ali
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (02) : 285 - 290
  • [42] Hemostatic Function of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology
    Ostrowski, S. R.
    Bochsen, L.
    Salado-Jimena, J. A.
    Ullum, H.
    Reynaerts, I.
    Goodrich, R. P.
    Johansson, P. I.
    [J]. TRANSFUSION, 2009, 49 : 97A - 98A
  • [43] PHOTOCHEMICAL INACTIVATION OF USUTU VIRUS USING THE MIRASOL PATHOGEN REDUCTION TECHNOLOGY (PRT) SYSTEM FOR PLATELETS
    Rossini, G.
    Silenzi, S.
    Govoni, M.
    Randi, V
    Pierro, A. M.
    Gaibani, P.
    Cavrini, F.
    Landini, M. P.
    Sambri, V
    [J]. VOX SANGUINIS, 2012, 103 : 188 - 188
  • [44] Effects of pathogen reduction technology treatment on platelet functions
    Terada, C.
    Okazaki, H.
    Satake, M.
    Tadokoro, K.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 323 - 323
  • [45] Filtration Leukoreduction Followed by Pathogen- Reduction (Mirasol Treatment) Prevents Alloimmune Platelet Refractoriness in a Dog Platelet Transfusion Model
    Slichter, Sherrill J.
    Pellham, Esther
    Bailey, S. Lawrence
    Christoffel, Todd
    [J]. BLOOD, 2012, 120 (21)
  • [46] PATHOGEN REDUCTION TECHNOLOGY WITH MIRASOL® FOR THE TREATMENT OF ORBISAC BUFFY COAT PLATELETS IN THE PRESENCE OF DIFFERENT ADDITIVE SOLUTIONS
    Yanez Izquierdo, M.
    Moya San Pedro, A.
    Blanco Penis, L.
    [J]. VOX SANGUINIS, 2010, 99 : 201 - 201
  • [47] Evaluation of the Mirasol platelet reduction technology system against Babesia microti in apheresis platelets and plasma
    Tonnetti, Laura
    Proctor, Melanie C.
    Reddy, Heather L.
    Goodrich, Raymond P.
    Leiby, David A.
    [J]. TRANSFUSION, 2010, 50 (05) : 1019 - 1027
  • [48] Mirasol ® Pathogen Reduction Technology treated FFP maintains protein quality after 2 years in storage
    Buytaart-Hoefen, Kimberley
    Hendrix, B.
    Bihm, D.
    Gampp, D.
    Miklauz, M.
    Goodrich, R.
    [J]. TRANSFUSION, 2008, 48 (02) : 145A - 146A
  • [49] Efficacy of the Mirasol pathogen reduction technology system against severe fever with thrombocytopenia syndrome virus (SFTSV)
    Shinohara, N.
    Matsumoto, C.
    Chatani, M.
    Uchida, S.
    Yoshikawa, T.
    Shimojima, M.
    Satake, M.
    Tadokoro, K.
    [J]. VOX SANGUINIS, 2015, 109 (04) : 417 - 419
  • [50] Molecular and cell biological evaluations of human WBC inactivation using Mirasol® pathogen reduction technology (PRT)
    Li, J
    McLean, R
    Goodrich, RP
    [J]. TRANSFUSION, 2005, 45 (03) : 29A - 29A
12345